While new research indicates that immunotherapy in men with localised, high-risk prostate cancer could offer benefits, there is still a long way to go before it becomes part of established treatment
While new research indicates that immunotherapy in men with localised, high-risk prostate cancer could offer benefits, there is still a long way to go before it becomes part of established treatment
<iframe src="https://hindustansphere.com/embed/cluster/830c075d4dd974cf3cd7152c2ddb30d84ab72db6" width="100%" height="320" style="border:0;max-width:680px" loading="lazy" title="A promising development in prostate cancer care: can immunotherapy help?"></iframe>
While new research indicates that immunotherapy in men with localised, high-risk prostate cancer could offer benefits, there is still a long way to go before it becomes part of established treatment
